Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Previving: How Unaffected Women with a BRCA1/2 Mutation Navigate Previvor Identity.

Getachew-Smith H, Ross AA, Scherr CL, Dean M, Clements ML.

Health Commun. 2019 Jun 4:1-10. doi: 10.1080/10410236.2019.1625002. [Epub ahead of print]

PMID:
31163995
2.

Lie to me: Tell me bald is beautiful.

Clements ML.

Ann Intern Med. 2018 Mar 6;168(5):373-374. doi: 10.7326/M17-2270. No abstract available.

PMID:
29507969
3.

Did Pre-Affordable Care Act Medicaid Expansion Increase Access to Surgical Cancer Care?

Al-Refaie WB, Zheng C, Jindal M, Clements ML, Toye P, Johnson LB, Xiao D, Westmoreland T, DeLeire T, Shara N.

J Am Coll Surg. 2017 Apr;224(4):662-669. doi: 10.1016/j.jamcollsurg.2016.12.044. Epub 2017 Jan 24.

4.

Having Cancer and Seeking the Point.

Clements ML.

Ann Intern Med. 2016 Dec 20;165(12):883. doi: 10.7326/M16-2480. No abstract available.

PMID:
27992914
5.

17 Lines About Chemo.

Clements ML.

JAMA Oncol. 2017 Feb 1;3(2):255. doi: 10.1001/jamaoncol.2016.3645. No abstract available.

PMID:
27787536
6.

Trauma and psychological distress in Latino citizen children following parental detention and deportation.

Rojas-Flores L, Clements ML, Hwang Koo J, London J.

Psychol Trauma. 2017 May;9(3):352-361. doi: 10.1037/tra0000177. Epub 2016 Aug 8.

PMID:
27504961
7.

Child and Parent Perceptions of Interparental Relationship Conflict Predict Preschool Children's Adjustment.

Clements ML, Martin SE, Randall DW, Kane KL.

Couple Family Psychol. 2014 Jun;3(2):110-125.

8.

Premarital precursors of marital infidelity.

Allen ES, Rhoades GK, Stanley SM, Markman HJ, Williams T, Melton J, Clements ML.

Fam Process. 2008 Jun;47(2):243-59.

PMID:
18605124
9.

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

RE-MOBILIZE Writing Committee, Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA.

J Arthroplasty. 2009 Jan;24(1):1-9. doi: 10.1016/j.arth.2008.01.132. Epub 2008 Apr 14.

PMID:
18534438
10.

Sacrifice as a predictor of marital outcomes.

Stanley SM, Whitton SW, Sadberry SL, Clements ML, Markman HJ.

Fam Process. 2006 Sep;45(3):289-303.

PMID:
16984071
11.

Mechanical load opposes angiotensin-mediated decrease in vascular alpha 1-adrenoceptors.

Clements ML, Faber JE.

Hypertension. 1997 May;29(5):1165-72.

PMID:
9149682
12.

Effect of mechanical loading on vascular alpha 1D- and alpha 1B-adrenergic receptor expression.

Clements ML, Banes AJ, Faber JE.

Hypertension. 1997 May;29(5):1156-64.

PMID:
9149681
13.

Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines.

Zolla-Pazner S, Alving C, Belshe R, Berman P, Burda S, Chigurupati P, Clements ML, Duliege AM, Excler JL, Hioe C, Kahn J, McElrath MJ, Sharpe S, Sinangil F, Steimer K, Walker MC, Wassef N, Xu S.

J Infect Dis. 1997 Apr;175(4):764-74.

PMID:
9086128
14.

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.

Ferrari G, Humphrey W, McElrath MJ, Excler JL, Duliege AM, Clements ML, Corey LC, Bolognesi DP, Weinhold KJ.

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1396-401.

15.

Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants.

Karron RA, Makhene M, Gay K, Wilson MH, Clements ML, Murphy BR.

Pediatr Infect Dis J. 1996 Aug;15(8):650-4.

PMID:
8858666
16.

Hepatitis B virus vaccination for older adults.

Bennett RG, Powers DC, Remsburg RE, Scheve A, Clements ML.

J Am Geriatr Soc. 1996 Jun;44(6):699-703.

PMID:
8642163
17.

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, McCutchan FE, Burke DS.

J Infect Dis. 1996 Feb;173(2):340-8.

PMID:
8568294
18.

Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.

Clements ML, Makhene MK, Karron RA, Murphy BR, Steinhoff MC, Subbarao K, Wilson MH, Wright PF.

J Infect Dis. 1996 Jan;173(1):44-51.

PMID:
8537681
19.

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children.

Karron RA, Wright PF, Newman FK, Makhene M, Thompson J, Samorodin R, Wilson MH, Anderson EL, Clements ML, Murphy BR, et al.

J Infect Dis. 1995 Dec;172(6):1445-50.

PMID:
7594701
20.

Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial.

Harrison K, Vlahov D, Jones K, Charron K, Clements ML.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1;10(3):386-90.

PMID:
7552502
21.

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.

Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J.

Vaccine. 1995 Aug;13(11):1006-12.

PMID:
8525683
22.
23.

Combination live respiratory virus vaccines.

Clements ML.

Ann N Y Acad Sci. 1995 May 31;754:351-5. No abstract available.

PMID:
7625672
24.

Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.

Karron RA, Steinhoff MC, Subbarao EK, Wilson MH, Macleod K, Clements ML, Fries LF, Murphy BR.

Pediatr Infect Dis J. 1995 Jan;14(1):10-6.

PMID:
7715982
25.

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Montefiori DC, McElrath MJ, Clements ML, et al.

AIDS Res Hum Retroviruses. 1994 Dec;10(12):1713-23.

PMID:
7888231
26.

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network.

Gorse GJ, Schwartz DH, Graham BS, Matthews TJ, Stablein DM, Frey SE, Belshe RB, Clements ML, Wright PF, Eibl M, et al.

Clin Exp Immunol. 1994 Nov;98(2):178-84.

27.

Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials Group.

Belshe RB, Clements ML, Keefer MC, Graham BS, Corey L, Sposto R, Wescott S, Lawrence D.

Ann Intern Med. 1994 Oct 15;121(8):584-9.

PMID:
8085690
28.

Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network.

Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R, et al.

J Infect Dis. 1994 Oct;170(4):782-6.

PMID:
7930718
29.

Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.

Clements ML, Miskovsky E, Davidson M, Cupps T, Kumwenda N, Sandman LA, West D, Hesley T, Ioli V, Miller W, et al.

J Infect Dis. 1994 Sep;170(3):510-6.

PMID:
8077707
30.

HIV infection in vaccinated volunteers.

Belshe RB, Bolognesi DP, Clements ML, Corey L, Dolin R, Mestecky J, Mulligan M, Stablein D, Wright P.

JAMA. 1994 Aug 10;272(6):431. No abstract available.

PMID:
8040971
31.

Comparison of the immune response to recombinant gp120 in humans and chimpanzees.

Berman PW, Eastman DJ, Wilkes DM, Nakamura GR, Gregory TJ, Schwartz D, Gorse G, Belshe R, Clements ML, Byrn RA.

AIDS. 1994 May;8(5):591-601.

PMID:
7520248
32.

Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials Network.

Keefer MC, Belshe R, Graham B, McElrath J, Clements ML, Sposto R, Fast P.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S139-40. No abstract available.

PMID:
7865288
33.
34.

Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.

Bollinger RC, Quinn TC, Liu AY, Stanhope PE, Hammond SA, Viveen R, Clements ML, Siliciano RF.

AIDS Res Hum Retroviruses. 1993 Nov;9(11):1067-77.

PMID:
7906131
35.

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine.

Schwartz DH, Gorse G, Clements ML, Belshe R, Izu A, Duliege AM, Berman P, Twaddell T, Stablein D, Sposto R, et al.

Lancet. 1993 Jul 10;342(8863):69-73.

PMID:
8100910
36.

Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.

Funkhouser A, Clements ML, Slome S, Clayman B, Viscidi R.

AIDS Res Hum Retroviruses. 1993 Jul;9(7):627-32.

PMID:
8369168
37.

Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine.

Stanhope PE, Clements ML, Siliciano RF.

J Infect Dis. 1993 Jul;168(1):92-100.

PMID:
8099941
38.

An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.

Stanhope PE, Liu AY, Pavlat W, Pitha PM, Clements ML, Siliciano RF.

J Immunol. 1993 May 15;150(10):4672-86.

PMID:
8097759
39.

Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.

Steinhoff MC, Fries LF, Karron RA, Clements ML, Murphy BR.

J Clin Microbiol. 1993 Apr;31(4):836-8.

40.

Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.

Fries LF, Dillon SB, Hildreth JE, Karron RA, Funkhouser AW, Friedman CJ, Jones CS, Culleton VG, Clements ML.

J Infect Dis. 1993 Mar;167(3):593-601.

PMID:
8440931
41.

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.

Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP, et al.

J Infect Dis. 1993 Mar;167(3):533-7.

PMID:
8095059
42.
43.

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network.

Graham BS, Belshe RB, Clements ML, Dolin R, Corey L, Wright PF, Gorse GJ, Midthun K, Keefer MC, Roberts NJ Jr, et al.

J Infect Dis. 1992 Aug;166(2):244-52.

PMID:
1353102
44.

Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children.

Belshe RB, Karron RA, Newman FK, Anderson EL, Nugent SL, Steinhoff M, Clements ML, Wilson MH, Hall SL, Tierney EL, et al.

J Clin Microbiol. 1992 Aug;30(8):2064-70.

45.
47.

Cell-mediated immune responses of adults to vaccination, challenge with Rickettsia rickettsii, or both.

Dumler JS, Wisseman CL Jr, Fiset P, Clements ML.

Am J Trop Med Hyg. 1992 Feb;46(2):105-15.

PMID:
1539743
48.

Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.

Powers DC, Murphy BR, Fries LF, Adler WH, Clements ML.

J Am Geriatr Soc. 1992 Feb;40(2):163-7.

PMID:
1740601
49.

Influenza vaccines.

Clements ML.

Biotechnology. 1992;20:129-50. Review. No abstract available.

PMID:
1600379
50.

Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants.

Midthun K, Halsey NA, Jett-Goheen M, Clements ML, Steinhoff M, King JC, Karron R, Wilson M, Burns B, Perkis V, et al.

J Infect Dis. 1991 Oct;164(4):792-6.

PMID:
1654365

Supplemental Content

Loading ...
Support Center